Skip to content

PTSD: all studies

Page 33 of 210: studies 321 to 330 of 2,096, newest first. Back to the PTSD overview

Research

Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD

BMJ Open May 1, 2023 Alan K. Davis, Adam W. Levin, Paul Nagib et al. 19 citations

Introduction Psilocybin-assisted therapy has shown significant promise in treating the cluster of mood and anxiety symptoms that comprise post-traumatic stress disorder (PTSD) but has yet to be tested specifically in this condition. Furthermore, current pharmacological and psychotherapeutic treatments for PTSD are difficult to tolerate and limited in efficacy, especially in the US Military...

Integrating Spirituality and Religious Beliefs in a Mindfulness Based Cognitive Behavioral Therapy for PTSD with Latinx Unaccompanied Immigrant Children

Journal of Child & Adolescent Trauma April 21, 2023 L. Fortuna, William Martinez, Michelle V. Porche

Purpose: Unaccompanied immigrant children (UIC) experience significant mental health concerns, particularly posttraumatic stress. This is a vulnerable population, yet little systematic research has examined the effectiveness of evidence-based models such as cognitive behavioral therapy (CBT) to meet their needs. Integrating religious beliefs and spirituality into therapy could elucidate better...

Development of a mobile mindfulness smartphone app for post-traumatic stress disorder and alcohol use problems for veterans: Beta test results and study protocol for a pilot randomized controlled trial.

Contemporary Clinical Trials April 12, 2023 Jordan P Davis, Eric R Pedersen, Brian Borsari et al.

Background: Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are highly prevalent, and co-occurring among post-9/11 veterans. Mobile health (mHealth) applications, specifically those focused on mindfulness-based techniques, may be an effective avenue to intervene with veterans who cannot or will not seek care at traditional in-person settings. Thus, to address areas of...

Neurobiological and Genetic Correlates of the Dissociative Subtype of PTSD

Journal of Psychopathology and Clinical Science April 6, 2023 E. Wolf, Sage E. Hawn, Danielle R. Sullivan et al.

Approximately 10–30% of individuals with posttraumatic stress disorder (PTSD) exhibit a dissociative subtype of the condition defined by symptoms of depersonalization and derealization. This study examined the psychometric evidence for the dissociative subtype of PTSD in a sample of young, primarily male post-9/11-era Veterans (n = 374 at baseline and n = 163 at follow-up) and evaluated its...

Agency in Post-traumatic Stress Disorder: Implications for Therapy

April 5, 2023 Vladimir Adrien, Marion Trousselard, Félix Schoeller 17 citations preprint

The concept of agency, or an individual's sense of control over their actions and external events, is important in the context of peritraumatic dissociation, and its cardinal importance in post-traumatic stress disorder (PTSD). This article provides a roadmap for the development of agency-based therapies in the future, along with offering an "enactive" perspective on trauma. We discuss the...

Beyond Mindfulness Assessed by Questionnaires: The Mindful-Breathing Exercise as an Additional Approach in PTSD and Depression

Mindfulness April 1, 2023 Stella Kümmerle, Thomas Heidenreich, Meike Müller-Engelmann

Abstract Objectives Despite various methodological concerns, previous studies mainly use questionnaires to assess mindfulness. Following a multi-measurement approach, the present study aimed to evaluate the added value of an experience-sampling measure in the context of posttraumatic stress disorder (PTSD) and depression. Method Data were collected in a PTSD group, depression group, and control...

MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail.

Australian & New Zealand Journal of Psychiatry April 1, 2023 Gillinder Bedi, Susan M Cotton, Alexandre A. Guerin et al. 17 citations

Recent years have seen escalating media, public and scientific interest in psychedelic medicine. Australia and New Zealand have been late to this research; however, in the past 2 years, rapid developments suggest that this is changing. Here, we argue for the need to critically review existing evidence in this field to guide future directions. We focus on...

Impact of Meditation on the Level of Post-traumatic Stress in Flood Victims of Sindh

Global Educational Studies Review March 30, 2023 H. Wahid, Maryam Hanif Ghazi, A. Lashari

This study aimed to find whether meditation can be effective in terms of post-traumatic stress(PSTD) or not. The purpose of this current study was to analyse the flood victims specifically (IDPs) by the influence of meditation on state post-traumatic stress. Guided meditation is helpful in reduction of the stress. The study analyses how meditation reduces the post-traumatic stress of IDP flood...

The Acceptability and Feasibility of a Virtual Mantram Program for Patients with Posttraumatic Stress Disorder and Substance Use Disorders: Mixed Method results

Research Square March 20, 2023 Ahmed N. Hassan, Sean Ferkul, Zena Agabani et al. preprint

Abstract Background : There is a need for expanded options for therapeutic interventions for patients with posttraumatic stress disorder (PTSD) and substance use disorder (SUD). The study aimed to examine evidence for the feasibility, safety, and acceptability of a virtual Mantram Repetition Program for adults with PTSD and SUD. Methods : This project utilized mixed-method design (explanatory...

DOI: 10.21203/rs.3.rs-2605978/v1 (opens in new tab) Full text (opens in new tab) Mindfulness Psychological intervention Substance abuse Clinical psychology +3

MDMA, Internal Family Systems therapy, and the Minnesota model in the resolution of C-PTSD-induced alcohol and diazepam addiction—A retrospective case study

March 10, 2023 Mika Turkia 1 citation preprint

In February 2023, Australia became the first country in the world to allow psychiatrists to prescribe 3,4-methylenedioxymethamphetamine (MDMA) for post-traumatic stress disorder (PTSD). This may have left interested clinicians looking for practical examples of the use of MDMA. In the 1950s and 1960s, psychedelics were successfully utilized in the treatment of alcoholism. This case study, the...